22 results
8-K
EX-99.2
STSA
Satsuma Pharmaceuticals Inc
20 Dec 22
Satsuma Pharmaceuticals Provides STS101 Development Program and Corporate Update
4:19pm
Commercial supply chain and commercial-scale manufacturing capability established Formulation manufacture by world-class CMO Manufacture of nasal delivery
S-3
0qn wtaxk62h4m2
23 Oct 20
Shelf registration
4:48pm
10-K
nvsex6ph3pnr
10 Mar 20
Annual report
4:20pm
10-Q
zaidvbi
12 Nov 19
Quarterly report
4:31pm
424B4
lu44zxviwhae6e
13 Sep 19
Prospectus supplement with pricing info
5:08pm
S-1/A
4l6pd6d3
3 Sep 19
IPO registration (amended)
6:12am
S-1
it1j3vkc
16 Aug 19
IPO registration
5:15pm